A detailed history of Morgan Stanley transactions in Enzo Biochem Inc stock. As of the latest transaction made, Morgan Stanley holds 67,342 shares of ENZ stock, worth $37,038. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,342
Previous 71,855 6.28%
Holding current value
$37,038
Previous $80,000 41.25%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$0.7 - $1.17 $3,159 - $5,280
-4,513 Reduced 6.28%
67,342 $47,000
Q3 2024

Nov 14, 2024

BUY
$1.04 - $1.18 $104 - $118
100 Added 0.14%
71,855 $80,000
Q1 2024

Aug 16, 2024

SELL
$1.21 - $1.5 $4,840 - $6,000
-4,000 Reduced 5.28%
71,755 $91,000
Q1 2024

May 15, 2024

SELL
$1.21 - $1.5 $4,840 - $6,000
-4,000 Reduced 5.28%
71,755 $91,000
Q4 2023

Aug 16, 2024

BUY
$1.21 - $1.44 $4,840 - $5,760
4,000 Added 5.57%
75,755 $105,000
Q4 2023

Feb 13, 2024

BUY
$1.21 - $1.44 $140 - $167
116 Added 0.15%
75,755 $105,000
Q3 2023

Nov 15, 2023

BUY
$1.3 - $1.87 $10,400 - $14,960
8,000 Added 11.83%
75,639 $105,000
Q2 2023

Aug 14, 2023

SELL
$1.84 - $2.66 $189,963 - $274,621
-103,241 Reduced 60.42%
67,639 $124,000
Q1 2023

May 15, 2023

SELL
$1.0 - $2.51 $196,422 - $493,019
-196,422 Reduced 53.48%
170,880 $415,000
Q4 2022

Feb 14, 2023

SELL
$1.16 - $2.42 $25,399 - $52,988
-21,896 Reduced 5.63%
367,302 $525,000
Q3 2022

Nov 14, 2022

SELL
$2.1 - $2.73 $66,271 - $86,153
-31,558 Reduced 7.5%
389,198 $867,000
Q2 2022

Oct 27, 2022

SELL
$2.0 - $3.0 $134,838 - $202,257
-67,419 Reduced 13.81%
420,756 $871,000
Q2 2022

Aug 15, 2022

SELL
$2.0 - $3.0 $134,838 - $202,257
-67,419 Reduced 13.81%
420,756 $871,000
Q1 2022

Oct 27, 2022

BUY
$2.9 - $3.47 $195,515 - $233,943
67,419 Added 16.02%
488,175 $1.42 Million
Q1 2022

May 13, 2022

BUY
$2.9 - $3.47 $1.36 Million - $1.63 Million
469,272 Added 2482.53%
488,175 $1.42 Million
Q4 2021

Feb 14, 2022

BUY
$3.17 - $4.09 $21,102 - $27,227
6,657 Added 54.36%
18,903 $60,000
Q3 2021

Nov 15, 2021

BUY
$3.01 - $3.77 $36,860 - $46,167
12,246 New
12,246 $44,000

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $26.8M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.